Innovating Works

H2020

Cerrada
HORIZON-CL3-2021-DRS-01-05
Fast deployed mobile laboratories to enhance situational awareness for pandemics and emerging infectious diseases
ExpectedOutcome:Projects’ results are expected to contribute to the following outcomes:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 23-11-2021.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Projects’ results are expected to contribute to the following outcomes:

Inventory and comparison of existing mobile laboratories, including heavy structures (both military and civilian) and light self-sustained systems, evaluation of quality management systems for maintenance, validation and testing. New (mobile laboratory) solutions for the fast, reliable and unambiguous detection and identification of infectious agents, diagnostic tests, monitoring and mapping of contamination and enhanced field data communication to decision-making authorities. Strategies to orchestrate mobile laboratory capacities in the EU, and improvements in the management of trained staff in Europe.
Scope:The recent COVID-19 crisis has demonstrated that the ability to rapidly identify viruses on scene under a proper quality control/assurance regime is crucial to ensure adequate risk assessment, optimal risk management, and proper counter measures. Consequently, a determining factor is to bring a rapidly deployable diagnostic capacity as close as possible to the crisis area. Considering specific infectious diseases is of paramount importance as also is the possibility to... ver más

ExpectedOutcome:Projects’ results are expected to contribute to the following outcomes:

Inventory and comparison of existing mobile laboratories, including heavy structures (both military and civilian) and light self-sustained systems, evaluation of quality management systems for maintenance, validation and testing. New (mobile laboratory) solutions for the fast, reliable and unambiguous detection and identification of infectious agents, diagnostic tests, monitoring and mapping of contamination and enhanced field data communication to decision-making authorities. Strategies to orchestrate mobile laboratory capacities in the EU, and improvements in the management of trained staff in Europe.
Scope:The recent COVID-19 crisis has demonstrated that the ability to rapidly identify viruses on scene under a proper quality control/assurance regime is crucial to ensure adequate risk assessment, optimal risk management, and proper counter measures. Consequently, a determining factor is to bring a rapidly deployable diagnostic capacity as close as possible to the crisis area. Considering specific infectious diseases is of paramount importance as also is the possibility to develop scalable capacities for joint multinational intervention. In the EU Civil Protection and Health policy framework, mobile laboratories are increasingly becoming part of crisis responses and recovery plans, and the COVID-19 illustrated the needs for further developments in this area. Pandemics risk mitigation comprises prevention, preparedness and post-crisis management, including networking, regional and international partnership, consolidating, coordinating and optimizing existing capabilities in terms of expertise, training, technical assistance and equipment. There is a need for building synergies among existing initiatives to develop an EU capacity building by strengthening the national and regional capacities and staff training for mobile laboratories operation, long-term sustainability culture of safety and security.

In order to achieve the expected outcomes, international cooperation is encouraged, in particular with Japan in the framework of the EU-Japan collaboration on pandemics.

Where possible and relevant, synergy-building and clustering initiatives with successful proposals in the same area should be considered, including the organisation of international conferences in close coordination with the Community for European Research and Innovation for Security (CERIS) activities and/or other international events.


Specific Topic Conditions:Activities are expected to achieve TRL 6-8 by the end of the project – see General Annex B.




Cross-cutting Priorities:International Cooperation


ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: ExpectedOutcome:Projects’ results are expected to contribute to the following outcomes: ExpectedOutcome:Projects’ results are expected to contribute to the following outcomes:
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 6:. Representa un paso importante en demostrar la madurez de una tecnología. Se construye un prototipo de alta fidelidad que aborda adecuadamente las cuestiones críticas de escala, que opera en un entorno relevante, y que debe ser a su vez una buena representación del entorno operativo real. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities. The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities.
Garantías: No existe condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.